Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.
Open | $0.713 |
Close | - |
Volume / Avg. | 2.171M / 4.071M |
Day Range | 0.700 - 0.829 |
52 Wk Range | 0.540 - 6.730 |
Market Cap | $113.589M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 17.44% |
Days to Cover | 6.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.
Other companies in Seres Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Barinthus Biotherapeutics (NASDAQ:BRNS) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Oppenheimer on Wednesday, March 6, 2024. The analyst firm set a price target for 5.00 expecting MCRB to rise to within 12 months (a possible 564.72% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $0.7522 last updated Today at April 25, 2024 at 11:45 AM EDT.
There are no upcoming dividends for Seres Therapeutics.
Seres Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Seres Therapeutics.
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.